150 related articles for article (PubMed ID: 15062056)
21. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
22. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
23. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer.
Sagara Y; Mimori K; Yoshinaga K; Tanaka F; Nishida K; Ohno S; Inoue H; Mori M
Br J Cancer; 2004 Aug; 91(5):959-65. PubMed ID: 15305200
[TBL] [Abstract][Full Text] [Related]
25. Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer.
Agudo D; Gómez-Esquer F; Martínez-Arribas F; Núñez-Villar MJ; Pollán M; Schneider J
Int J Cancer; 2004 May; 109(5):717-20. PubMed ID: 14999780
[TBL] [Abstract][Full Text] [Related]
26. [Expression and clinical significance of KNSL4 in breast cancer].
Feng YM; Wan YF; Li XQ; Cao XC; Li X
Ai Zheng; 2006 Jun; 25(6):744-8. PubMed ID: 16764773
[TBL] [Abstract][Full Text] [Related]
27. [Abnormal expression of RSK-4 and its clinical significance in breast cancer].
Liu JL; Yang HW; Chen ZS; Jiang Y
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):452-6. PubMed ID: 21875487
[TBL] [Abstract][Full Text] [Related]
28. [Expression of KLK6 protein and mRNA in primary breast cancer and its clinical significance].
Wang SM; Mao J; Li B; Wu W; Tang LL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1087-9. PubMed ID: 18992199
[TBL] [Abstract][Full Text] [Related]
29. A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk.
Katz E; Dubois-Marshall S; Sims AH; Faratian D; Li J; Smith ES; Quinn JA; Edward M; Meehan RR; Evans EE; Langdon SP; Harrison DJ
Br J Cancer; 2010 Jul; 103(3):401-10. PubMed ID: 20628393
[TBL] [Abstract][Full Text] [Related]
30. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
[TBL] [Abstract][Full Text] [Related]
31. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
Wang L; Devarajan E; He J; Reddy SP; Dai JL
Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
[TBL] [Abstract][Full Text] [Related]
32. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
33. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
34. Expression and methylation status of the Syk gene in cervical carcinoma.
Zhao S; Sun G; Tony PW; Ma D; Zhao C
Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
[TBL] [Abstract][Full Text] [Related]
35. [Significance of membrane type-1 matrix metalloproteinase expression in breast cancer].
Yao GY; Yang MT; Rong TH; He P
Ai Zheng; 2004 Nov; 23(11 Suppl):1482-6. PubMed ID: 15566663
[TBL] [Abstract][Full Text] [Related]
36. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R
Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938
[TBL] [Abstract][Full Text] [Related]
37. [Expression of SM22α and its relationship with lymph node metastasis in breast cancer].
MA ZF; CUI NP; SHI JH; WANG HY; SHI SH; WEN M; LI Z
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2545-8. PubMed ID: 21092460
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
39. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.
Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D
Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920
[TBL] [Abstract][Full Text] [Related]
40. High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
Coebergh van den Braak RRJ; Sieuwerts AM; Kandimalla R; Lalmahomed ZS; Bril SI; van Galen A; Smid M; Biermann K; van Krieken JHJM; Kloosterman WP; Foekens JA; Goel A; Martens JWM; IJzermans JNM;
PLoS One; 2017; 12(9):e0185607. PubMed ID: 28957395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
